Inspira Technologies Receives Notice from Nasdaq for Non-Compliance with Listing Rule
RA’ANANA, Israel, March 13, 2025
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), a leading innovator in life-support and diagnostic technologies, recently announced that it had received a written notice (the “Notice”) from the Nasdaq Stock Market LLC. The Notice stated that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the closing bid price for its ordinary shares, or Ordinary Shares, had been below $1.00 per share for the last 30 consecutive business days.
Impact on Inspira Technologies
The receipt of the Notice from Nasdaq represents a significant setback for Inspira Technologies. The Company will now have 180 calendar days, or until September 12, 2025, to regain compliance with the Nasdaq Listing Rule. If the Company’s Ordinary Shares do not meet the minimum bid price requirement of $1.00 per share for a minimum of ten consecutive business days during this period, then the Company may be subject to delisting from the Nasdaq Stock Market.
The potential delisting from Nasdaq could have several negative consequences for Inspira Technologies. First, it may lead to a decrease in investor confidence, which could result in a further decline in the Company’s stock price. Additionally, being delisted from Nasdaq could make it more difficult for the Company to attract new investors and raise capital in the future.
Impact on Individual Investors
Individual investors who own Inspira Technologies’ Ordinary Shares may be affected by the Company’s non-compliance with Nasdaq Listing Rule 5550(a)(2) in several ways.
- Decreased Liquidity: If the Company is delisted from Nasdaq, it may become more difficult for investors to buy and sell their shares. This could lead to decreased liquidity and potentially larger spreads between the bid and ask prices.
- Increased Risk: The potential delisting could increase the risk associated with holding Inspira Technologies’ Ordinary Shares. If the Company is unable to regain compliance with the Nasdaq Listing Rule, it may face financial and operational challenges that could impact its long-term viability.
- Possible Loss of Value: If investor confidence in Inspira Technologies wanes, the value of the Company’s Ordinary Shares could decline significantly.
Impact on the World
The potential delisting of Inspira Technologies from Nasdaq could have broader implications beyond the Company and its investors.
- Reduced Innovation: Inspira Technologies is a pioneer in innovative life-support and diagnostic technologies. If the Company is unable to regain compliance with Nasdaq Listing Rule 5550(a)(2), it may face financial and operational challenges that could hinder its ability to continue developing and bringing new technologies to market.
- Economic Impact: The potential delisting could have economic implications, particularly in Israel, where Inspira Technologies is based. The Company employs over 500 people and is a significant contributor to the local economy.
- Market Volatility: The potential delisting could contribute to market volatility, particularly in the healthcare technology sector.
Conclusion
The receipt of the Notice from Nasdaq is a significant development for Inspira Technologies and its investors. The potential delisting from Nasdaq could have far-reaching consequences, including decreased liquidity, increased risk, potential loss of value, reduced innovation, economic impact, and market volatility. The Company will now have 180 calendar days to regain compliance with Nasdaq Listing Rule 5550(a)(2). If it is unable to do so, it may face delisting from the Nasdaq Stock Market, which could have significant consequences for the Company, its investors, and the broader healthcare technology sector.
It is important for investors to stay informed about the Company’s progress in regaining compliance with Nasdaq Listing Rule 5550(a)(2) and to consider the potential risks and rewards of holding Inspira Technologies’ Ordinary Shares. The Company’s management team and investors will need to work together to address the underlying issues that led to the receipt of the Notice and to position the Company for long-term success.
